
ALTERNATIVES TO IVF: WHAT OPTIONS ARE THERE IF IT DOES NOT SUCCEED
CONTENTS
- Key points
- The first step: what exactly failed?
- The first real alternative: a change of strategy, not simple repetition
- The second alternative: egg donation or other forms of donor treatment
- The third alternative: proper investigation of implantation failure, without excess
- What to watch out for with add-ons
- The key points
- Important note
- Useful sources
- Frequently asked questions
- 1A failed cycle does not mean the options have run out — it calls for a thorough reassessment, not a mechanical repetition.
- 2The first step is to determine at which stage the cycle failed: ovarian response, fertilisation, embryo development or implantation.
- 3A change of protocol only makes sense when it is based on the data from the previous cycle.
- 4When egg quality is the main limiting factor, egg donation is a medically recognised alternative.
- 5For most add-on measures there is no conclusive evidence that they increase success rates.
When an IVF cycle is unsuccessful, the hardest question is not "what went wrong?" but "what is the right next step?". At that point, many patients feel the need to try everything: different protocols, other medicines, additional tests, add-on interventions, different timing. The right strategy, however, is not to apply everything, but to select, in a targeted way, the interventions that have real value.
A failed cycle does not mean that the options have run out. It does, however, signal the need for a genuine reassessment rather than a mechanical repetition. In this process, the alternatives should be set out clearly: which options are supported by scientific evidence, which are add-on solutions still under discussion, and which lack sufficient supporting data.
The first step: what exactly failed?
Not all failures are the same. Having an inadequate ovarian response, retrieving eggs that then fail to fertilise, or having embryos that do not develop satisfactorily are each different scenarios from an embryo transfer that does not lead to implantation. The HFEA explains that treatment failure can arise at different stages of the process, which is why the assessment must be specific and individual.
If this is not identified, there is a risk of "changing treatment" without a clear goal. The right approach includes a detailed review of the cycle: how many eggs were retrieved, how the ovaries responded, what quality of embryos resulted, where the main limiting factor lay, and which findings relate most to age, sperm, the endometrium or the biology of the gametes themselves.
The first real alternative: a change of strategy, not simple repetition
In some cases, the next step is to modify the stimulation protocol or the treatment strategy. This may include a different approach to egg retrieval, different timing or a redefinition of the goals of the cycle. However, any change only makes sense when it is based on the data from the previous cycle.
In other words, "let's do another one and see" is not a strategy. A strategy is a targeted adjustment based on the cause – that is, knowing whether the previous cycle failed because the response was poor, because of egg quality, or because implantation did not occur for reasons that require separate investigation.
The second alternative: egg donation or other forms of donor treatment
When age and egg quality are the main limiting factor, egg donation is a real, medically recognised alternative. The ASRM recognises it as the standard of practice for age-related infertility, as it can bypass the age-related decline in implantation and birth rates.
This does not mean it is the right choice for every woman. However, when the data indicate that the problem lies mainly in the quality or availability of eggs, this alternative should be discussed openly.
The third alternative: proper investigation of implantation failure, without excess
In cases of recurrent implantation failure, there is often strong pressure to carry out many additional tests and treatments. Caution is needed here. ESHRE stresses that many of the tests and interventions discussed for investigating implantation failure are not recommended routinely or require stronger evidence. So the aim is not to do everything, but to carry out the right, individualised investigation.
This is particularly important because the anxiety that follows repeated failures can easily make unproven solutions seem attractive. Good medical practice is not built on anxiety, but on evidence.
What to watch out for with add-ons
The HFEA states explicitly that there is no conclusive evidence that most of the commonly used add-ons increase success rates. This does not mean there can never be a place for a specialised intervention. It does mean, however, that not every add-on should be presented as a hidden key that simply had not been tried yet.
When the discussion shifts to add-on interventions before the underlying cause of failure has been clarified, there is a risk of losing the real direction of treatment. And this often prolongs the journey without meaningfully improving the prognosis.
The key points
A failed IVF cycle does not mean a dead end. The options exist, but the right next move is rarely the most impressive one. The best strategy is the one based on the data from the previous cycle, on the real biology of the case and on an honest discussion of what has a chance of working and what does not. The best alternative is not doing more, but taking the most precisely targeted next step.
Important note
This article is for information only and does not replace an individual medical assessment. Decisions about further testing, the choice of treatment and the timeline should be made together with a specialist in reproductive medicine.
Useful sources
What patients often ask
A detailed reassessment of the cycle: how many eggs were retrieved, how the ovaries responded, what quality of embryos resulted and where the main limiting factor lay. The aim is a targeted next step, not simply a repeat.
In some cases, yes, but any change only makes sense when it is based on the data from the previous cycle — for example, if the response was poor or if the problem concerned egg quality.
When age and egg quality are the main limiting factor. ASRM recognises it as the standard of practice for age-related infertility, although it is not the right option for every woman.
According to the HFEA, there is no conclusive evidence that most add-ons increase success rates. The decision on any specialised intervention should be based on the underlying cause of the failure.
He supports scientific excellence in clinical practice and recognizes the possibilities offered by modern reproductive methods to couples who wish to have a child of their own.
His profileThe content of this article is for information only and does not replace a medical examination and advice.
